Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update

Please wait...

+302107210001info@primarycare.grΜαιάνδρου 23Τ.Κ. 11528, Αττική

This report assesses SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA.

previousE-learning: COVID-19 infection prevention and control

nextCommunicable disease threats report, 6 - 12 June 2021, week 23

H Ελληνική Εταιρεία Έρευνας και Εκπαίδευσης στην Πρωτοβάθμια Φροντίδα Υγείας αποτελεί μια επιστημονική εταιρεία με σκοπό τη βελτίωση της ποιότητας των υπηρεσιών υγείας που παρέχονται από τους ιατρούς της Π.Φ.Υ. μέσω εκπαιδευτικών προγραμμάτων και ερευνητικών διαδικασιών.

Latest news

22/09/2023
Communicable disease threats report, 17-23 September 2023, week 38
21/09/2023
ECDC Director: Protect people’s health this autumn through vaccination and other preventive measures

Designed and powered by Onedata.gr 2023

%d bloggers like this:

Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update

Like this:

Related

previousE-learning: COVID-19 infection prevention and control

nextCommunicable disease threats report, 6 - 12 June 2021, week 23

Communicable disease threats report, 17-23 September 2023, week 38

ECDC Director: Protect people’s health this autumn through vaccination and other preventive measures

Communicable disease threats report, 10-16 September 2023, week 37

Latest news

Communicable disease threats report, 17-23 September 2023, week 38

ECDC Director: Protect people’s health this autumn through vaccination and other preventive measures

Share this:

Like this:

Related

previousE-learning: COVID-19 infection prevention and control

nextCommunicable disease threats report, 6 - 12 June 2021, week 23

Latest news